Moon‐Kyu Lee

Suggest Changes
  • Citations Per Year
Learn More
BACKGROUND Gemigliptin is a new dipeptidyl peptidase-IV inhibitor. We investigated the efficacy and safety of initial combination therapy with gemigliptin and metformin compared with monotherapy with(More)
  • 1